2007Acta Academiae Medicinae JiangxiRequires access

Pharmacokinetics and Bioequivalance of Ibuprofen Tablet in Healthy Volunteers

Yuqing Xiong

Open publisher page 0 citations

Abstract

Objective To investigate pharmacokinetic of Ibuprofen and to evaluate the bioequivalance.Methods Eighteen healthy male volunteers were enrolled into the single crossover study.After a single dose of the suspension equivalent to 400 mg Ibuprofen or a reference preparation were given by crossover.To develop a sensitive and specific HPLC-UV method for the determination of Ibuprofen in human plasma.The bioequivalence of the suspension and reference were evaluated by pharmacokinetic parameters and relative bioavailability obtained.Results The main pharmacokinetic parameters of test and reference Ibuprofen were as the followings:AUC 0-10 was(125.40±20.74)μg/(mL·h)and(130.38±24.79)μg/(mL·h);C max was(34.60±7.12)μg/mL and(37.88±7.13)μg/mL;T max was(2.0±0.5)h and(1.7±0.5)h;t 1/2 was(2.1±0.21)h and(2.19±0.29)h.The relative bioavailability of test to reference preparation was(98.2±18.7)%.Conclusion The two preparations are bioequivalent.

About this research paper

What this paper is about

Objective To investigate pharmacokinetic of Ibuprofen and to evaluate the bioequivalance.Methods Eighteen healthy male volunteers were enrolled into the single crossover study.After a single dose of the suspension equivalent to 400 mg Ibuprofen or a reference preparation were given by crossover.To develop a sensitive and specific HPLC-UV method for the determination of Ibuprofen in human plasma.The bioequivalence of the suspension and reference were evaluated by pharmacokinetic parameters and relative bioavailability obtained.Results The main pharmacokinetic parameters of test and reference Ibuprofen were as the followings:AUC 0-10 was(125.40±20.74)μg/(mL·h)and(130.38±24.79)μg/(mL·h);C max was(34.60±7.12)μg/mL and(37.88±7.13)μg/mL;T max was(2.0±0.5)h and(1.7±0.5)h;t 1/2 was(2.1±0.21)h and(2.19±0.29)h.The relative bioavailability of test to reference preparation was(98.2±18.7)%.Conclusion The two preparations are bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate pharmacokinetic of Ibuprofen and to evaluate the bioequivalance.Methods Eighteen healthy male volunteers were enrolled into the single crossover study.After a single dose of the suspension equivalent to 400 mg Ibuprofen or a reference preparation were given by crossover.To develop a sensitive and specific HPLC-UV method for the determination of Ibuprofen in human plasma.The bioequivalence of the suspension and reference were evaluated by pharmacokinetic parameters and relative bioavailability obtained.Results The main pharmacokinetic parameters of test and reference Ibuprofen were as the followings:AUC 0-10 was(125.40±20.74)μg/(mL·h)and(130.38±24.79)μg/(mL·h);C max was(34.60±7.12)μg/mL and(37.88±7.13)μg/mL;T max was(2.0±0.5)h and(1.7±0.5)h;t 1/2 was(2.1±0.21)h and(2.19±0.29)h.The relative bioavailability of test to reference preparation was(98.2±18.7)%.Conclusion The two preparations are bioequivalent.

Key concepts: Bioequivalence, Pharmacokinetics, Ibuprofen, Bioavailability, Crossover study, High-performance liquid chromatography, Chromatography, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics and Bioequivalance of Ibuprofen Tablet in Healthy Volunteers — Research Paper | ScholarLens